Abstract:Importance: The clinical outcomes associated with masked hypertension defined by home blood pressure monitoring (HBPM) in clinical settings remain uncertain.Objective: To assess the association between masked hypertension and cardiovascular disease events in clinical settings.Design, Setting, and Participants: This observational cohort study used data from 4261 outpatients treated at 71 primary practices or university hospitals throughout Japan who were enrolled in the Japan Morning Surge-Home Blood Pressure study between January 1, 2005, and December 31, 2012. Participants had a history of or risk factors for cardiovascular disease and were followed up through March 31, 2015. Participants underwent clinic blood pressure (BP) measurements on 2 occasions as well as HBPM measurements in the morning and evening for a 14-day period. Urine albumin to creatinine ratio and circulating brain (or B-type) natriuretic peptide levels were quantified at baseline as a marker of cardiovascular end-organ damage. Data were analyzed from July 1, 2017, to October 31, 2017.Exposures: Participants were categorized into 4 BP groups: (1) masked hypertension-hypertensive home BP levels (systolic, ≥135 mm Hg; diastolic, ≥85 mm Hg) and nonhypertensive clinic BP levels (systolic, <140 mm Hg; diastolic, <90 mm Hg); (2) white-coat hypertension-nonhypertensive home BP levels (systolic, <135 mm Hg; diastolic, <85 mm Hg) and hypertensive clinic BP levels (systolic, ≥140 mm Hg; diastolic, ≥90 mm Hg); (3) sustained hypertension-hypertensive home and clinic BP levels; and (4) controlled BP-nonhypertensive home and clinic BP levels.Main Outcomes and Measures: Incident stroke and coronary heart disease.Results: Of the 4261 participants, 2266 (53.2%) were women, 3374 (79.2%) were taking antihypertensive medication, and the mean (SD) age was 64.9 (10.9) years. During a median (interquartile range) follow-up of 3.9 (2.4-4.6) years, 74 stroke (4.4 per 1000 person-years) and 77 coronary heart disease (4.6 per 1000 person-years) events occurred. The masked hypertension group had a greater risk for stroke compared with the controlled BP group (hazard ratio, 2.77; 95% CI, 1.20-6.37), independent of traditional cardiovascular risk factors, urine albumin to creatinine ratio, and circulating B-type natriuretic peptide levels. Conversely, masked hypertension yielded no association with coronary heart disease risk.Conclusions and Relevance: In the Japanese general practice population, masked hypertension defined by HBPM may be associated with an increased risk for stroke events. Use of HBPM may improve the assessment of BP-related risks and identify new therapeutic interventions aimed at preventing cardiovascular disease events.

Masked phenomenon: renal and cardiovascular complications; review and updates

Blood Pressure Characteristics in Moderate to Severe Renal Insufficiency

Prevalence and factors associated with masked hypertension in chronic kidney disease

Ambulatory blood pressure monitoring in Egyptian children with nephrotic syndrome: single center experience

Blood Pressure and Chronic Kidney Disease Progression: An Updated Review

Association of Cardiovascular Outcomes With Masked Hypertension Defined by Home Blood Pressure Monitoring in a Japanese General Practice Population

Utility of 24-hour ambulatory blood pressure monitoring for detecting masked hypertension and masked uncontrolled hypertension

Study to assess the patterns of hypertension and factors influencing hypertension in chronic kidney disease

Revisiting Hypertension Treatment in Patients With Chronic Kidney Disease

Hypertension In Chronic Kidney Disease: Novel Insights.

Ambulatory Blood Pressure, Left Ventricular Hypertrophy, and Allograft Function in Children and Young Adults After Kidney Transplantation

Machine Learning–Based Prediction of Masked Hypertension Among Children With Chronic Kidney Disease

Prognostic effect of masked morning hypertension in Chinese inpatients with non-dialysis chronic kidney disease: A multi-center retrospective study

Hypertension in chronic kidney disease: What lies behind the scene

Utility of ambulatory blood pressure monitoring in detection of masked hypertension and risk of hypertension mediated organ damage in normotensive patients with type 2 diabetes mellitus

Hypertension as Cardiovascular Risk Factor in Chronic Kidney Disease

Role and prognostic value of individual ambulatory blood pressure components in chronic kidney disease

Out-of-office blood pressure monitoring in chronic kidney disease

Review of Renal Artery Stenosis and Hypertension: Diagnosis, Management, and Recent Randomized Control Trials

Diagnosis and treatment of hypertension in dialysis patients: a systematic review